910 related articles for article (PubMed ID: 17706954)
1. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway.
Min LJ; Mogi M; Tamura K; Iwanami J; Sakata A; Fujita T; Tsukuda K; Jing F; Iwai M; Horiuchi M
J Mol Cell Cardiol; 2009 Dec; 47(6):798-809. PubMed ID: 19769983
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.
Min LJ; Mogi M; Li JM; Iwanami J; Iwai M; Horiuchi M
Circ Res; 2005 Sep; 97(5):434-42. PubMed ID: 16081869
[TBL] [Abstract][Full Text] [Related]
4. Signaling mechanisms of angiotensin II in regulating vascular senescence.
Min LJ; Mogi M; Iwai M; Horiuchi M
Ageing Res Rev; 2009 Apr; 8(2):113-21. PubMed ID: 19162241
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol attenuates angiotensin II-induced senescence of vascular smooth muscle cells.
Ichiki T; Miyazaki R; Kamiharaguchi A; Hashimoto T; Matsuura H; Kitamoto S; Tokunou T; Sunagawa K
Regul Pept; 2012 Aug; 177(1-3):35-9. PubMed ID: 22561451
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 2 receptor deletion enhances vascular senescence by methyl methanesulfonate sensitive 2 inhibition.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Hypertension; 2008 May; 51(5):1339-44. PubMed ID: 18362223
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
[TBL] [Abstract][Full Text] [Related]
9. Nicotine enhances angiotensin II-induced mitogenic response in vascular smooth muscle cells and fibroblasts.
Li JM; Cui TX; Shiuchi T; Liu HW; Min LJ; Okumura M; Jinno T; Wu L; Iwai M; Horiuchi M
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):80-4. PubMed ID: 14592853
[TBL] [Abstract][Full Text] [Related]
10. Insulin-stimulated NADH/NAD+ redox state increases NAD(P)H oxidase activity in cultured rat vascular smooth muscle cells.
Yang M; Kahn AM
Am J Hypertens; 2006 Jun; 19(6):587-92. PubMed ID: 16733230
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat.
Li X; Meng Y; Wu P; Zhang Z; Yang X
Regul Pept; 2007 Jan; 138(1):15-25. PubMed ID: 16971004
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells.
Lavrentyev EN; Estes AM; Malik KU
Circ Res; 2007 Aug; 101(5):455-64. PubMed ID: 17626897
[TBL] [Abstract][Full Text] [Related]
13. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
[TBL] [Abstract][Full Text] [Related]
14. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system.
Corry DB; Eslami P; Yamamoto K; Nyby MD; Makino H; Tuck ML
J Hypertens; 2008 Feb; 26(2):269-75. PubMed ID: 18192841
[TBL] [Abstract][Full Text] [Related]
15. Losartan inhibits STAT1 activation and protects human glomerular mesangial cells from angiotensin II induced premature senescence.
Jiao S; Zheng X; Yang X; Zhang J; Wang L
Can J Physiol Pharmacol; 2012 Jan; 90(1):89-98. PubMed ID: 22217266
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R
Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756
[TBL] [Abstract][Full Text] [Related]
17. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
18. Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells.
Imanishi T; Hano T; Nishio I
Hypertens Res; 2005 Mar; 28(3):263-71. PubMed ID: 16097371
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
20. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
Kai H; Fukui T; Lassègue B; Shah A; Minieri CA; Griendling KK
Mol Pharmacol; 1996 Jan; 49(1):96-104. PubMed ID: 8569718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
